FGF2 Alters Expression of the Pyrophosphate/Phosphate Regulating Proteins, PC-1, ANK and TNAP, in the Calvarial Osteoblastic Cell Line, MC3T3E1(C4)

REFERENCES

• Moerlooze L. D., Dickson C. Skeletal disorders associated with fibroblast growth factor receptor mutations. Curr. Op. Gen. Dev. 1997; 7: 378–385, [CSA]
   PubMed Web of Science ®Google Scholar
• Ornitz D. M., Marie P. J. FGF Signaling in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 2002; 16: 1446–1465, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Marie P. J. Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 2003; 316: 23–32, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Register T. C., Wuthier R. E. The effect of pyrophosphate and two diphosphonates on 45Ca and 32Pi uptake and mineralization by matrix vesicle-enriched fractions and by hydroxyapatite. Bone 1985; 6: 307–312, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Anderson H. C., Sipe J. B., Hessle L., Dhamyamraju R., Atti E., Camacho N. P., Millan J. L. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am. J. Path. 2004; 164: 841–847, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Terkeltaub R., Rosenbach M., Fong F., Goding J. Causal link between nucleotide pyrophosphohydrolase over activity and increased intracellular inorganic pyrophosphate generation demonstrated by transfection of cultured fibroblasts and osteoblasts with plasma cell membrane glyoprotein-1. Arthrit. Rheum. 1994; 37: 934–941, [CSA]
   PubMed Web of Science ®Google Scholar
• Fleisch H., Straumann F., Schenk R., Bisaz S., Allgower M. Effect of condensed phosphates on calcification of chick embryo femurs in tissue culture. Am. J. Physiol. 1966; 211: 821–825, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Johnson K., Moffa A., Chen Y., Prizker K., Goding J., Terkeltaub R. Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells. J. Bone Min. Res. 1999; 14: 883–892, [CSA]
   PubMed Web of Science ®Google Scholar
• Johnson K. A., Hessle L., Vaingankar S., Wennerg C., Mauro S., Narisawa S., Goding J. W., Sano K., Millan J. L., Terkeltaub R. Osteoblast tissue-nonspecific alkaline phosphatase antagonizs and regulates PC-1. Am. J. Physiol. Int. Comp. Physiol. 2000; 279: 1365–R1377, [CSA]
   PubMed Web of Science ®Google Scholar
• Hessle L., Johnson K. A., Anderson H. C., Narisawa S., Sali A., Goding J. W., Terkeltaub R., Millan J. L. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc. Nat. Acad. Sci. 2002; 99: 9445–9449, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Johnson K., Goding J., Van Etten D., Sali A., Hu S., Farley D., Krug H., Hessle L., Millan J. L., Terkeltaub R. Linked deficiencies in extracellular PPi and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression. J. Bone Min. Res. 2003; 18: 994–1004, [CSA]
   PubMed Web of Science ®Google Scholar
• Johnson K., Hashimoto S., Lotz M., Pritzker K., Goding J., Terkeltaub R. Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification. Arthritis Rheum. 2001; 44: 1071–1081, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Solan J. L., Deftos L. J., Goding J. W., Terkeltaub R. A. Expression of the nucleoside triphosphate pyrophosphohydrolase PC-1 is induced by basic fibroblast growth factor (bFGF) and modulated by activation of the protein kinase A and C pathways in osteoblast-like osteosarcoma cells. J. Bone Min. Res. 1996; 11: 183–192, [CSA]
   PubMed Web of Science ®Google Scholar
• Terkeltaub R. A., Johnson K., Rohnow D., Goomer R., Burton D., Deftos L. J. Bone morphogenetic proteins and bFGF exert opposing regulatory effects on PTHrP expression and inorganic pyrophosphate elaboration in immortalized murine endochondral hypertrophic chondrocytes (MCT cells). J. Bone Min. Res. 1998; 13: 931–941, [CSA]
   PubMed Web of Science ®Google Scholar
• Wennberg C., Hessle L., Lundberg P., Mauro S., Narisawa S., Lerner U. H., Millan J. L. Functional chracterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice. J. Bone Min. Res. 2000; 15: 1879–1888, [CSA]
   PubMed Web of Science ®Google Scholar
• Fedde K. N., Blair L., Silverstein J., Coburn S. P., Ryan L. M., Weinstein R. S., Waymire K., Narisawa S., Millan J. L., Macgregor G. R., Whyte M. P. Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J. Bone Min. Res. 1999; 14: 2015–2026, [CSA]
   PubMed Web of Science ®Google Scholar
• Reyes-Botella C., Ballecillo-Capilla M. F., Ruiz C. Effect of different growth factors on human cultured osteoblast-like cells. Cell Physiol. Biochem. 2002; 12: 353–358, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Pereira R. C., Exonomides A. M., Canalis E. Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts. Endocrinology 2000; 141: 4558–4563, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Walsh S., Jefferiss C., Stewart K., Jordan G. R., Screen J., Beresford J. M. Expression of the developmental markers STRO-1 and alkaline phosphatase in cultures of human marrow stromal cells: regulation by fibroblast growth factor (FGF)-2 and relationship to the expression of FGF receptors 1-4. Bone 2000; 27: 185–195, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mansukhani A., Bellosta P., Sahni M., Basilico C. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J. Bone Min. Res. 2000; 149: 1297–1308, [CSA]
   Google Scholar
• Debiais F., Hott M., Graulet A. M., Marie P. J. The effects of fibroblast growth factor-2 on human neonatal calvarial osteoblastic cells are differentiation stage specific. J. Bone Min. Res. 1998; 13: 645–654, [CSA]
   PubMed Web of Science ®Google Scholar
• Pendleton A., Johnson M. D., Hughe S A., Gurley K. A., Ho A. M., Doherty M., Dixey J., Gillet P., Loeuille D., McGrath R., Reginato A., Shiang R., Wright G., Netter P., Williams C., Kingsley D. M. Mutations in ANKH cause chondrocalcinosis. Am. J. Hum. Gen. 2002; 71: 933–940, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Reichenberger E., Tiziani V., Watanabe S., Park L., Ueki Y., Santanne C., Baur S. T., Shiang R., Grange D. K., Beighton B., Garner J., Hamersma H., Sellars S., Ramesar R., Lidral A. S., Raposo do Amaral C. M., Gorlin R. J., Mulliken J. B., Olsen B. R. Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am. J. Hum. Gen. 2001; 68: 1321–1326, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nurnberg P., Thiele H., Chandler D., Hohne W., Cunningham M. L., Ritter H., Leschik G., Uhlmann K., Mischung C., Harrop K., Goldblatt J., Borochowitz Z. U., Kotzot D., Westermann F., Mundlos S., Braun H., Laing N., Tinschert S. Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia. Nat. Gen. 2001; 28: 37–41, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ho A. M., Johnson M. D., Kingsley D. M. Role of the mouse ank gene in control of tissue calcification and arthritis. Science 2000; 289: 265–270, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sohn P., Crowley M., Slattery E., Serra R. Developmental and TGF-β mediated regulation of Ank mRNA expression in cartilage and bone. Osteoarthr. Cart. 2002; 10: 482–490, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Guo Y., Hsu D., Sheau-Line Y. F., Richards C. M., Winkles J. A. Polypeptide growth factors and phorbol ester induce progressive ankylosis (ank) gene expression in murine and human fibroblasts. J. Cell Biochem. 2002; 84: 27–38, [CSA], [CROSSREF]
   Web of Science ®Google Scholar
• Choi J., Lee B., Song K., Park R., Kim I., Sohn K., Jo J., Ryoo H. Expression patterns of bone-related proteins during osteoblastic differentiation in MC3T3-E1 cells. J. Cell. Biochem. 1996; 61: 609–618, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sudo H., Kodama H., Amagai Y., Yamamoto S., Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell. Bio. 1983; 96: 191–198, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wang D., Christensen K., Chawla K., Xiao G., Krebsbach P., Franceschi R. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J. Bone Min. Res. 1999; 14: 893–903, [CSA]
   PubMed Web of Science ®Google Scholar
• Locklin R. M., Khosla S., Turner R. T., Biggs B. L. Mediators of the biphasic response of bone to intermittent and continuously administered parathyroid hormone. J. Cell. Biochem. 2003; 89: 180–190, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hughes F. J., Collyer J., Stanfield M., Goodman S. A. The effects of bone morphogenetic protein-2,-4 and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology 1995; 136: 2671–2677, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Warren S. M., Brunet L. J., Harland R. M., Economides A. N., Longaker M. T. The BMP antagonist noggin regulates cranial suture fusion. Nature 2003; 422: 625–629, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Xiao G., Gopalakrishman R., Jiang D., Reith E., Benson M. D., Franceschi R. T. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J. Bone Min. Res. 2002; 17: 101–110, [CSA]
   PubMed Web of Science ®Google Scholar
• Kalajzic I., Kalajzic Z., Hurley M. M., Lichtler A. C., Rowe D. W. Stage specific inhibition of osteoblast lineage differentiation by FGF2 and noggin. J. Cell. Biochem. 2003; 88: 1168–1176, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Burgar H. R., Burns H. D., Elsden J. L., Lalioti M. D., Heath J. K. Association of the signaling adaptor FRS2 with fibroblast growth factor receptor 1 (Fgfr1) is mediated by alternative splicing of the juxtamembrane domain. J. Bio. Chem. 2002; 277: 4018–4123, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Debiais F., Lemonnier J., Hay E., Delannoy P., Caverzasio J., Marie P. J. Fibroblast growth factor-2 (FGF) increases N-cadherin expression through protein kinase C and src-kinase pathways in human calvarial osteoblasts. J. Cell. Biochem. 2001; 81: 68–81, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Newberry E. P., Willis D., Latifi T., Boudreasux J. M., Towler D. A. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element. Mol. End. 1997; 11: 1129–1144, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kim H., Kin J., Bae S., Choi J., Kim H., Ryoo H. The protein kinase C pathway plays a central role in the FGF-stimulated expression and transactivation activity of run× 2. J. Biol. Chem. 2003; 278: 319–326, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Leclerc C., Duprat A., Moreau M. Noggin upregulates fos expression by a calcium-mediated pathway in amphibian embryos. Dev. Growth. Diff. 1999; 41: 227–238, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rawadi G., Vayssiere B., Dunn F., Baron R., Roman-Roman S. BMP-2 controls alkaline phosphates expression and osteoblast mineralization by a Wnt autocrine loop. J. Bone Min. Res. 2003; 18: 1842–1853, [CSA]
   PubMed Web of Science ®Google Scholar
• Whyte M. P., Landt M., Ryan L. M., Mulivor R. A., Henthorn P. S., Fedde K. N., Mahuren J. D., Coburn S. P. Alkaline phosphatase: placental and tissue-non-specific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5′-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy. J Clin Inv. 1999; 95: 1440–1445, [CSA]
   Web of Science ®Google Scholar
• Kreiborg S. Crouzon syndrome: a clinical and roentgencephalometric study. Scan. J. Plast. Reconstr. Surg. 1981; 18, suppl[CSA]
   Google Scholar
• Chen L. Li., Cuiling L., Engel A., Deng C. A Ser250Trp substitution in mouse fibroblast growth factor receptor (Fgfr2) results in craniosynostosis. Bone 2003; 33: 169–178, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Johnson K., Terkeltaub R. Upregulated ank expression in osteoarthritis can promote both chondrocyte MMP-13 expression and calcification via chondrocyte extracellular PPi excess. Osteoarthr. Cart. 2004; 12: 321–335, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar